HMGB1 and bacterial infectious disease with sepsis: Neutralizing the extracellular HMGB1 using anti-HMGB1 monoclonal antibodies significantly increased the survival during lethal endotoxemia or bacterial sepsis (Lamkanfi et al., 2010; Qin et al., 2006; Wang et al., 1999).